Caliway Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat
Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) regulatory pathway. The company has received the EOP2 meeting minutes, confirming the primary endpoints and pivotal study design for the Approval in Reduction...
SolarEast Launches Global R290 Heat Pump System to Advance Climate Goals and Energy Efficiency
BEIJING, May 14, 2025 /PRNewswire/ -- SolarEast, a leading manufacturer of air-to-water heat pumps, has announced the global launch of its next-generation R290-based heating and cooling solution. Designed for both residential and commercial buildings, this system combines environmental sustainability, regulatory compliance, and advanced smart technology, positioning itself as a key contributor to the global energy transition. Meeting International...
GC Biopharma Receives FDA Approval for its U.S. Plasma Collection Center in Calexico, California
YONGIN, South Korea, May 14, 2025 /PRNewswire/ -- GC Biopharma, a South Korean pharmaceutical company, announced that its U.S. subsidiary, ABO Holdings, has received FDA approval for its plasma collection center located in Calexico, California. Following the successful U.S. launch of ALYGLO (immune globulin intravenous, human-stwk) 10% Liquid, GC Biopharma acquired ABO...
Novonesis Co-Hosts Partnering Day 2025 in Singapore to Advance Biosolutions for a Sustainable Future
SINGAPORE, May 13, 2025 /PRNewswire/ -- Novonesis, a world-leading biosolutions company, co-hosted its "Unlocking Value for a Sustainable Future" Partnering Day 2025 in Singapore on May 7 together with Novo Holdings and Flagship Pioneering. The event focused on reshaping the agriculture and food industries through biosolutions and resource recycling. Leaders from food, agri-business, and waste management explored resource optimisation, while...
Avance Clinical Honored with Frost & Sullivan’s 2025 Global Customer Value Leadership Award for Transformative Biotech CRO Services
This award recognizes Avance Clinical's strategic innovation, operational agility, and unwavering commitment to client success in early-phase clinical trials. SAN ANTONIO, May 14, 2025 /PRNewswire/ -- Frost & Sullivan has named Avance Clinical the recipient of its 2025 Global Customer Value Leadership Award in the biotech contract research organization (CRO) sector, highlighting the company's outstanding performance in delivering exceptional client value...
Cariflex Opens World’s Largest Polyisoprene Latex Plant in Singapore, Following Over US$350 Million Investment
New facility increases Cariflex's global manufacturing capacity, with future expansion already enabled to meet growing market demand in the foreseeable future SINGAPORE, May 14, 2025 /PRNewswire/ -- Cariflex Pte. Ltd. (Cariflex), the global market leader in polyisoprene rubber latex for medical-end markets and wholly owned subsidiary of DL Chemical Co., Ltd. (DL...
Dymax Launches TPO-Free Light-Curable Adhesives Range to Address Regulatory and Marketplace Demands
SINGAPORE, May 14, 2025 /PRNewswire/ -- Dymax, a leading manufacturer of rapid light-curing materials and equipment, responds to market interest in sustainable adhesive solutions and changing regulatory requirements by expanding its portfolio of TPO-free light-curable materials. Preemptive Compliance and Long-Term ReadinessIn anticipation of the European Union legislative changes on Trimethylbenzoyl Diphenylphosphine Oxide (TPO) and in response to growing...
Dupixent approved in Singapore as the first-ever biologic medicine for patients with COPD
Following recent approvals in the EU, US and China, the Singapore approval is based on two replicate phase 3 studies that showed Dupixent achieved significant reduction in exacerbations, and also showed improvements in lung function and health-related quality of life compared to placebo. SINGAPORE, May 14,...
iotaMotion Announces First Use of Robotic-Assisted Cochlear Implant Technology Outside the U.S. as Part of Clinical Investigation in Switzerland
ST. PAUL, Minn., May 14, 2025 /PRNewswire/ -- iotaMotion, Inc., a leader in robotic-assisted systems for cochlear implant surgery, today announced the first use of the iotaSOFT® Insertion System outside of the United States. The technology is in use as a pre-market clinical investigation at University Hospital of Zurich, led...
Ubie and CMI Media Group Partner to Modernize DTC Advertising with Highly Personalized Consumer Campaigns in Women’s Health, Hematology
There is a critical need for trustworthy, hyper-personalized information earlier in the diagnosis and treatment journey to empower patients to participate in their care The partnership will initially focus on endometriosis and hematology; high-need therapeutic areas where patients are actively seeking information Connecting tailored information with relevant, motivated audiences...
